title: Absidia corymbifera necrotizing cellulitis in an immunocompromised patient while on voriconazole treatment.
authors.forename: Maria Bruna
authors.initials: MB
authors.lastname: Pasticci
authors.forename: Adelmo
authors.initials: A
authors.lastname: Terenzi
authors.forename: Luigi Maria
authors.initials: LM
authors.lastname: Lapalorcia
authors.forename: Paolo
authors.initials: P
authors.lastname: Giovenale
authors.forename: Lucia
authors.initials: L
authors.lastname: Pitzurra
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Costantini
authors.forename: Alessandra
authors.initials: A
authors.lastname: Lignani
authors.forename: Grazia
authors.initials: G
authors.lastname: Gurdo
authors.forename: Fabio
authors.initials: F
authors.lastname: Verzini
authors.forename: Franco
authors.initials: F
authors.lastname: Baldelli
mesh_terms: D020095:Absidia; D000368:Aged; D000935:Antifungal Agents / Q000627:therapeutic use; D048909:Diabetes Complications / Q000382:microbiology; D018409:Foot Injuries / Q000276:immunology / Q000382:microbiology*; D006801:Humans; D016867:Immunocompromised Host; D015470:Leukemia, Myeloid, Acute / Q000150:complications* / Q000276:immunology; D008297:Male; D009091:Mucormycosis / Q000276:immunology*; D011743:Pyrimidines / Q000627:therapeutic use; D014230:Triazoles / Q000627:therapeutic use; D065819:Voriconazole
chemical_list: D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole